Healis Therapeutics
Healis Therapeutics is a privately held biotechnology company that is develop botulinum toxin as a potential treatment for Major Depressive Disorder (MDD).

Year Established: 2006
Stock Ticker:
Exchange:
Healis Therapeutics is a privately held biotechnology company that is develop botulinum toxin as a potential treatment for Major Depressive Disorder (MDD).
Healis Therapeutics is a privately held biotechnology company that is develop botulinum toxin as a potential treatment for Major Depressive Disorder (MDD).
Healis Therapeutics is a privately held biotechnology company that is develop botulinum toxin as a potential treatment for Major Depressive Disorder (MDD).